NCT00171080View on ClinicalTrials.gov

VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Hypertension
Interventions
DRUG

valsartan

DRUG

irbesartan

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00171080 - VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis | Biotech Hunter | Biotech Hunter